A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
Clinical trial NCT03685500 · COMPLETED
Trial details
- NCT number
- NCT03685500
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-04
- Primary completion
- 2020-06-25
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.